{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T04:14:55Z","timestamp":1749096895996,"version":"3.41.0"},"reference-count":0,"publisher":"SanovaWorks","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JDD"],"published-print":{"date-parts":[[2025,6,1]]},"DOI":"10.36849\/jdd.8720","type":"journal-article","created":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T17:10:44Z","timestamp":1749057044000},"page":"590-598","source":"Crossref","is-referenced-by-count":0,"title":["Clinical Profile of Halobetasol Propionate 0.01%\/ Tazarotene 0.045% Lotion in Patients With Hyperkeratotic Plaque Psoriasis"],"prefix":"10.36849","volume":"24","author":[{"given":"Emil","family":"Tanghetti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Stein Gold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward","family":"Lain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abby","family":"Abby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"22713","published-online":{"date-parts":[[2025,5,1]]},"container-title":["Journal of Drugs in Dermatology"],"original-title":[],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T17:10:49Z","timestamp":1749057049000},"score":1,"resource":{"primary":{"URL":"https:\/\/jddonline.com\/articles\/dermatology\/S1545961625P8720X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,1]]},"references-count":0,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,5,1]]},"published-print":{"date-parts":[[2025,6,1]]}},"URL":"https:\/\/doi.org\/10.36849\/jdd.8720","relation":{},"ISSN":["1545-9616"],"issn-type":[{"value":"1545-9616","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,1]]}}}